Fresenius Medical Care AG & Co. (Pref) (ETR:FME) has been assigned a €95.40 ($112.24) target price by stock analysts at J P Morgan Chase & Co in a report issued on Thursday. The brokerage currently has a “buy” rating on the stock.

A number of other equities research analysts also recently issued reports on FME. UBS AG set a €68.00 ($80.00) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a “sell” rating in a research report on Friday, July 14th. Oddo Securities set a €95.00 ($111.76) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a research report on Thursday, July 20th. Goldman Sachs Group, Inc. (The) set a €98.00 ($115.29) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a research report on Monday, July 24th. Deutsche Bank AG set a €85.00 ($100.00) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a “neutral” rating in a research report on Monday, July 24th. Finally, Berenberg Bank set a €92.10 ($108.35) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a research report on Wednesday, July 26th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and nine have given a buy rating to the company. Fresenius Medical Care AG & Co. (Pref) currently has an average rating of “Hold” and an average target price of €89.12 ($104.84).

TRADEMARK VIOLATION WARNING: “Fresenius Medical Care AG & Co. (Pref) (FME) PT Set at €95.40 by J P Morgan Chase & Co” was first posted by American Banking News and is owned by of American Banking News. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of US and international copyright & trademark laws. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/11/02/fresenius-medical-care-ag-95-40-by-j-p-morgan-chase-co-2.html.

About Fresenius Medical Care AG & Co. (Pref)

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. (Pref) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. (Pref) and related companies with MarketBeat.com's FREE daily email newsletter.